Location History:
- Gunma, JP (2015 - 2016)
- Tokyo, JP (2007 - 2019)
Company Filing History:
4 out of 2,253 
3 out of 272 
1 out of 340 
Years Active: 2007-2019
Title: Takahiro Nakajima: Innovator in Oligonucleotide Technology
Introduction
Takahiro Nakajima is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of oligonucleotide technology, holding a total of 8 patents. His work focuses on improving the efficacy of oligonucleotides, which are essential in various biomedical applications.
Latest Patents
Among his latest patents, Nakajima has developed an oligonucleotide with improved affinity for AGO2. This oligonucleotide features a nucleotide residue or a nucleoside residue that enhances its binding capabilities. Additionally, he has patented a method for improving the knockdown activity of oligonucleotides targeting mRNA associated with disease-related proteins. Another notable patent involves an oligonucleotide with a non-natural nucleotide at its 5'-terminal, which also demonstrates enhanced binding properties.
Career Highlights
Throughout his career, Nakajima has worked with notable companies such as Adv Antest Corporation and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has allowed him to refine his expertise in oligonucleotide research and development.
Collaborations
Takahiro Nakajima has collaborated with esteemed colleagues, including Hajime Sugimura and Takeshi Yaguchi. These partnerships have contributed to the advancement of his innovative work in the field.
Conclusion
Takahiro Nakajima is a distinguished inventor whose contributions to oligonucleotide technology have the potential to impact various medical fields. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and improving therapeutic strategies.